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Gastritis and gastric ulcers are an important cause of morbidity and mortality in canine 
athletes. Although the majority of scientific work on this condition has been performed 
in ultraendurance racing sled dogs, this condition has been identified in other canine 
athletes, including sled dogs competing in shorter events and dogs performing off-
leash explosive detection duties. The cause of the syndrome is unknown, but current 
hypotheses propose a link between exercise-induced hyperthermia and loss of gastric 
mucosal barrier function as an early event in the pathogenesis. Treatment is focused on 
prevention of clinical disease using acid secretion inhibitors, such as omeprazole, which 
has excellent efficacy in controlled clinical studies.
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iNTRODUCTiON
Gastritis and gastric ulcers can be an important cause of morbidity and mortality in canine athletes, 
most notably racing sled dogs but also other athletic dog populations. This review will outline the 
important points regarding this condition, including prevalence and risk factors, clinical syndrome, 
pathophysiology, and treatment and prevention strategies.
PRevALeNCe AND iMPORTANCe
The importance of exercise-induced gastric disease (EIGD) in dogs is highlighted by both the 
frequency with which this syndrome is directly or indirectly related to mortality, but also the more 
insidious effect on performance and overall thriftiness. For the past two decades, organized ultraen-
durance sled dog racing has required the meticulous documentation of sled dog deaths in an attempt 
to provide transparency to the fans and critics of the sport as well as identify areas of canine health 
and well-being that require additional investigation. These reports showed that from 1994 to 2006, 
23 dogs died during the 13 Iditarod races held during that time span (1). Eleven of those deaths were 
either directly or indirectly related to gastric disease (blood loss or vomiting and aspiration of gastric 
contents, respectively). Comprehensively collated statistics such as these are not available for other 
major races, but anecdotal evidence supports a similar proportional pattern (albeit with smaller 
numbers overall due to the fewer numbers of dogs involved in these other events). These statistics 
do not reflect the unknown number of dogs that may have been affected in a less severe manner, and 
were dropped off at checkpoints along the racecourse. Strenuous exercise requires the consumption 
of considerable amounts of food and water – ultraendurance racing sled dogs will burn from 8000 to 
12000 kcal/day (2, 3) and turnover 5 l of bodywater/day (4). Any illness that reduces a dog’s appetite 
or makes them reluctant to eat or drink or promotes vomiting/regurgitation – as gastric disease is 
known to do – will rapidly cause poor performance and dehydration under these conditions.
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Some of the earliest studies of the prevalence of gastric disease 
in athletic dogs were done in association with the Iditarod Sled 
Dog race. In 2000, a small pilot study was performed to follow-up 
on anecdotal work done by Drs. Jack Morris and Phil Meyer, in 
which they reported frequently finding gastric lesions in dogs fol-
lowing the race. The 2000 study was conducted on dogs returning 
from the race, and found a gastric lesion prevalence of approxi-
mately 35% in dogs that were examined from 3 to 7 days post-
exercise (5). Some of these subjects had completed the race, but 
most had been “dropped” for various medical reasons (not always 
due to suspected gastrointestinal disease). The first systematic 
evaluation of gastric health in racing sled dogs was performed 
the following year. Gastric endoscopy was performed on 73 dogs 
within 24 h of finishing the race (5). Using the visible presence 
of at least one area of erosion or ulceration in the gastric mucosa 
as the criterion, nearly half of the dogs had endoscopically visible 
lesions that were considered clinically significant. This percentage 
has held up through seven different studies: unmedicated racing 
sled dogs can be expected to have between 50 and 70% prevalence 
of clinically significant lesions after at least a single day of exercise 
(6), whether it is a long training day (7), a mid-distance race (8), 
or one of the ultraendurance races (5, 9–11). It seems intuitive 
that exercise intensity has some influence on disease severity, but 
further discussion of this type requires more careful definition of 
“exercise intensity,” which can be quantified many different ways. 
Within the scope of a 1000+-mile race, finishing place does not 
seem to have a major influence on prevalence – teams finishing in 
12 days (averaging 83 miles/day) had similar prevalence values to 
teams finishing in 9 days (averaging 111 miles/day) (5). Although 
data are not available from this study to assess whether the dif-
ference in daily distance was due to higher speeds or shorter rests 
in the teams finishing in 9  days, in general the lower-placing 
teams do so by resting longer as well as traveling slower. Teams 
competing in mid-distance races averaging 150 miles/day, during 
which substantially less rest/day is taken compared to the longer 
distance races, had noticeably higher prevalence and average 
gastric endoscopy severity scores (ESSs), suggesting that intensity 
of exercise (or something that is strongly correlated to intensity of 
exercise) has an influence on EIGD (8).
There have been studies of other athletic dog populations 
that have helped clarify the scope of this issue in the world of 
canine athletes. A study of field trial retrievers participating in a 
simulated single-day competition found a statistically significant 
worsening of the gastric endoscopy scores, but the scores stayed 
within the range that is considered not clinically significant 
(12). Thus, this population is probably not at risk for exercise-
induced gastritis/gastric ulcers as a primary disease process, but 
consideration should be given to taking preventive measures if an 
individual competitive dog has additional risk factors for gastric 
disease. On the other hand, retrievers used for off-leash explosive 
detection work (during which the dogs may be exercising inter-
mittently for up to 9 h/day) had an 84% prevalence of clinically 
severe gastric ulcers after five consecutive days of exercise, with 
the mean endoscopy score of the exercising dogs being higher 
than any other group of exercising dogs examined in other studies 
(13). Thus, it is clear that dogs other than racing sled dogs are at 
risk for EIGD if they perform sufficiently strenuous exercise.
DeFiNiTiON OF CLiNiCAL SYNDROMe
Perhaps the most frustrating aspect to this disease is that the over-
whelming majority of affected dogs are subclinical, as evidenced 
by the fact that all endoscopy studies to date have been done in 
dogs that were clinically normal – having completed a grueling 
competition and/or having passed the physical examination 
that preceded the general anesthesia for endoscopy (5–11, 13). 
At the opposite end of this clinical spectrum are the dogs that 
are withdrawn from competition due to unequivocal evidence 
of gastric disease (i.e., repeated vomition or vomiting of fresh 
blood, aspiration pneumonia), but these dogs are relatively rare. 
The proportion of dogs that are withdrawn from competition that 
may have EIGD as an underlying cause (for example, due to lack 
of appetite or dehydration) is unknown, but it is likely that these 
“dropped” dogs have a prevalence at least as high as those dogs 
that continue to perform well.
There are no clinical pathology measurements that have been 
shown to characterize EIGD reliably. With the exception of the 
relatively rare instance in which the disease progresses to severe, 
acute, or chronic blood loss, decreased erythrocyte and serum 
protein concentrations are common in dogs performing endur-
ance exercise (14), but not consistently associated with EIGD. 
Hematocrit may decrease in response to plasma volume expan-
sion, which is a known and predictable conditioning response 
(15). Thus, differentiating mild hemodilution secondary to a 
desirable conditioning effect from occult moderate blood loss can 
be challenging in the athletic dog population. Serum cortisol pre-
dictably increases in exercise challenged dogs (16–19), likely due 
to the need for gluconeogenesis to offset the increased demand 
for glucose as a metabolic fuel (20), thus decreasing the useful-
ness of assessing serum cortisol as an indicator of physiological 
stress that could predispose to EIGD. In the studies in which this 
marker has been reported in the same dogs for which gastric 
examinations were performed, there was no association between 
serum cortisol and gastric disease on an individual dog basis 
(even though there was concurrent increase in serum cortisol and 
gastric disease in athletic dogs as a group) (11), suggesting that 
the increases in serum cortisol were not related either causally or 
as an effect of EIGD.
Endoscopy remains the gold standard for the diagnosis 
of EIGD in dogs due to the lack of consistent clinical signs or 
laboratory indices in the majority of the affected dogs. The range 
of severity of endoscopic findings can be substantial, from a 
few submucosal petechia to multiple actively bleeding lesions. 
A subjective severity scoring system has been established in 
which a stomach completely free of visible lesions is scored as 0; 
a stomach with a few submucosal petechia but no visible defects 
in the mucosa is scored as 1, a dog with extensive areas of erosions 
OR a single bleeding ulcer is scored as 2, and a dog with multiple 
bleeding ulcers is scored as 3 (Figure 1). Lesions can be found in 
all regions of the stomach, and through hundreds of examinations 
a particular bias in lesion location within the stomach has not been 
identified. Endoscopic assessment of motility, while subjective, is 
noteworthy in that as opposed to impaired motility (which can be 
associated with gastric lesions), the typical athletic dog appears to 
have enhanced gastrointestinal motility. The stomach of a trained 
FiGURe 1 | endoscopy severity score (eSS) guide. (A) ESS = 0; (B) ESS = 1; (C) ESS = 2; (D) ESS = 3.
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working dog routinely can be examined, free of ingesta, after only 
a 12-h fast. Though of minimal scientific value, this observation 
may have considerable logistical value in deciding whether to 
perform gastric endoscopy on a dog with suspected EIGD.
Histopathology of dogs affected with EIGD has provided 
important clues regarding the pathophysiology of the disease. 
As a general practice, biopsies are obtained from normal-
appearing areas of the gastric mucosa to avoid the secondary 
inflammation and necrosis that is expected in areas of actively 
bleeding lesions. Nevertheless, these biopsies have consistently 
demonstrated chronic mononuclear inflammation (5, 21), sug-
gesting that although the gross lesions may have appeared in 
<24 h, the underlying pathological process has been occurring 
much longer – often predating the exercise session that appears 
to have caused the gastric mucosal disruption. Of particular 
interest is histopathological evidence of extensive apoptosis of 
grossly normal mucosa, suggesting that the terminal event in the 
pathophysiology is the programed cell death and sloughing of the 
mucosal epithelium, rather than chemical erosion and damage 
of the cells by stomach acid. Evidence of chronic mononuclear 
inflammation is present even in dogs that have been rested for up 
to 4 months (21). This type of chronic inflammation is not present 
in field trial retrievers (12), supporting both the contention that 
this population of dogs is not affected routinely by EIGD and 
the possible role of chronic mononuclear inflammation in the 
development of EIGD.
PATHOPHYSiOLOGY
There are few studies that specifically address the mechanisms 
underlying the development of EIGD in dogs. Increased per-
meability of the gastrointestinal mucosa has been measured in 
response to exercise in racing sled dogs (6, 10, 11). Although it 
is impossible to determine whether the loss of barrier function 
measured in these studies reflects an early pathophysiological 
event or is the result of the disease, it is worthwhile to note 
that the magnitude of increase in serum sucrose (a marker of 
permeability of the gastric mucosa) did not correlate with the 
endoscopically assessed severity of gastric mucosal disruption. 
With increased paracellular permeability, virtually anything that 
is in the lumen can find its way into the walls of the respective 
organs. In the stomach, the primary noxious material for diffu-
sion is acid. With chronic, repeated periods of hyperthermia, 
the intermittent paracellular acid leak not only causes chronic 
subclinical inflammation (demonstrated in clinically normal, 
fully trained sled dogs prior to competitive exercise) but also sets 
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the stage for acute exacerbation of the disease on the first day of 
competition.
The possibility of increased mucosal permeability as an early 
event is supported by studies in rodents and humans, demonstrat-
ing that physiological hyperthermia comparable to the magnitude 
routinely documented in exercising dogs will result in increased 
transmucosal permeability of other segments of the gastrointesti-
nal tract (22–24). A primary role of hyperthermia-induced loss of 
gastrointestinal mucosal barrier function is further supported by 
the consistency between disease severity and the time-weighted 
duration of hyperthermia when all studies are considered: explo-
sive detection dogs will achieve and sustain remarkably high 
rectal temperatures during simulated deployment activities (13), 
higher than is routinely found in racing sled dogs. In turn, rac-
ing sled dogs that are participating in relatively shorter distance 
events (300 miles) will tend to maintain higher speeds and rest 
less often than dogs competing in the ultraendurance events of 
1000 miles. Finally, training runs tend to be slower and shorter in 
duration than racing, presumably resulting in less hyperthermia. 
Although this correlation is admittedly crude, its general fidelity 
with the population-wide variations in gastric disease severity, 
combined with the mechanistic data available in other species, 
makes hyperthermia-induced mucosal permeability a leading 
candidate for the initiating step in this syndrome.
The effects of “stress” are often cited as the cause of gastric 
ulcers in a variety of animals and circumstances. Commonly, 
physiological stress is quantified through the measurement 
of serum or salivary cortisol  –  an approach that may be too 
simplistic to provide a clear explanation or mechanistic basis. 
Glucocorticoids have a very wide range of biological activities, 
including the upregulation of hepatic gluconeogenesis (20), so 
it is not surprising that increases in serum cortisol are measured 
routinely during and following strenuous exercise (16–19) when 
the rate of glucose oxidation by working muscle greatly increases 
(25). Although the association between large doses of exogenous 
corticosteroids and gastric ulcers has been documented (26), 
a similar association between endogenous corticosteroids and 
gastric disease is more problematic for the simple reason that 
when investigators document concurrent hypercortisolemia and 
gastric disease, it is impossible to determine whether the increased 
release of cortisol is causing the disease or a response to the 
disease (or both). Similarly, in exercising animals – particularly 
those with modest increases in serum cortisol that are consistent 
with the requirement for increased glucose availability, it is dif-
ficult to make a firm association between hypercortisolemia and 
gastric disease. Indeed, in the single study reporting concurrent 
measurements, there was not an individual association between 
the magnitude of gastric disease and serum cortisol concentration 
(11). Thus, the role of glucocorticoids in the pathophysiology of 
exercise-induced gastrointestinal disease remains unconfirmed.
Increased secretion of gastrin (a potent gastric acid secre-
tagogue) has been documented in both human (27–29) and 
equine athletes (30), and is believed to contribute to EIGD 
in these species through increased gastric acidity. Although a 
potential role for gastric acid in the pathogenesis of EIGD in 
dogs can be suggested due to the documented protective effects 
of acid suppressing medications, neither increased gastrin nor 
gastric hyperacidity has been documented in athletic dogs at 
this time. Therefore, the potential role for increased gastrin 
secretion in the pathogenesis of EIGD remains possible, but 
speculative.
There are many proposed causes of EIGD in dogs, but none 
that have been definitively proven at this time. Many, however, 
can be regarded as unlikely as major contributing factors to 
the disease in general. For example, the distribution of lesions 
observed during gastroscopy (widely distributed with no par-
ticular region predominantly affected) would tend to discount 
the possibilities of direct tissue trauma such as might occur when 
sled dogs are fed frozen snacks (5). The possibility of trauma 
secondary to ingestion of frozen food can be further disregarded 
in light of the prevalence of gastric lesions in studies in which 
the dietary intake of the dogs was closely controlled (8, 13). The 
fact that severe lesions have been found in individual dogs in 
one year and virtually nothing the following year (or vice versa) 
tends to reduce the likelihood of individual susceptibility as a 
major contributing factor. While the possibility that a high-fat 
diet may contribute to susceptibility cannot be discounted (since 
virtually all athletic dogs are consuming a high-fat diet in order 
to match energy intake with expenditure, even the military 
explosive detection dogs), minor variations in diet composition 
within that broad category of “high energy” diets do not seem 
to have a major influence on disease prevalence. Whether the 
high-fat diets routinely used in these types of canine athletes 
predispose to EIGD has not been examined. Gastric pathogens, 
such as Helicobacter pylori, are a major cause of gastric disease 
in humans and, therefore, the possibility of these organisms as a 
contributing cause to canine EIGD has been investigated. Special 
stains on biopsies obtained in three different studies have failed 
to demonstrate consistently the presence of helical bacteria, and 
in the instances in which these genera were detected, there was 
no association with either visible or histopathological evidence 
of disease (5, 21). Finally, exercise-induced ischemia due to the 
redistribution of visceral blood flow is possible in dogs for which 
the intensity of exercise exceeds the capacity of the cardiovas-
cular system. However, direct measurements of visceral blood 
flow in trained sled dogs exercising at typical ultraendurance 
racing speeds found no reduction in splanchnic blood flow (31), 
suggesting that at least in these populations (as well as popula-
tions exercising at a similar intensity or lower such as explosive 
detection dogs), splanchnic ischemia is not a major factor in the 
development of EIGD.
Non-steroidal anti-inflammatory drugs (NSAIDs) deserve 
special mention due to their well-known ulcerogenic potential 
(32–34). Although it is possible that concurrent administration 
of NSAIDs could have an additive or synergistic role in promot-
ing gastric disease in exercising dogs, it should be noted that 
all of the studies to date that have demonstrated EIGD in dogs 
have been done in circumstances in which NSAID use was pro-
hibited [either in organized competition in which random drug 
testing is a prominent feature (5, 8–10) or in controlled studies 
in which the investigators could exclude the use of NSAIDs 
(6–8, 13)]. Thus, it can be safely concluded that NSAIDs are 
not a necessary component of the pathophysiology of EIGD 
in dogs.
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TReATMeNT AND PReveNTiON
The treatment of EIGD in dogs is not dissimilar to the treatment 
of gastric ulcers of any cause, with the sole exception of cessation 
of the inciting cause (exercise) being a prominent aspect of EIGD 
treatment. Acid suppression is the most important component 
in the treatment and prevention of gastric ulcers. There are two 
main drug classes currently in use in veterinary medicine for 
acid suppression. Histamine-2 (H2) receptor antagonists, such 
as cimetidine, ranitidine and famotidine, act to suppress gastric 
acid secretion by binding the H2 receptors of gastric parietal 
cells, thus, preventing the secretion of both hydrochloric acid and 
pepsin. Proton pump inhibitors, such as omeprazole, act to block 
the H+–K+ATPase proton pump that is the final stage of gastric 
acid secretion. While proton pump inhibitors are considerably 
more potent antacids than H2 blockers, the realities of dosing 
should be considered in drug selection. Unlike proton pump 
inhibitors, H2 antagonists have good oral bioavailability when 
administered with food, and, therefore, need not be administered 
on an empty stomach as is the case with omeprazole. This fact 
is significant when one considers the difficulties of manual oral 
administration to dogs in extreme conditions or situations, and 
that frequent meals are required to meet the caloric demands 
of heavily exercising dogs making administration on an empty 
stomach problematic. To further illustrate this point, the efficacy 
of omeprazole in preventing gastric ulcers in sled dogs under 
racing conditions was the first preventive therapy investigated 
by Davis et al. (9), and the results were disappointing, showing 
that omeprazole was only moderately effective in preventing 
clinically significant gastric ulcers in dogs finishing the Iditarod 
Sled Dog race. Further unpublished research later determined 
that the absorption of proton pump inhibitors administered with 
a meal to dogs was extremely poor. With this in mind, the authors 
undertook a series of studies to determine the effectiveness of 
famotidine (which is well absorbed in the presence of food) in 
preventing gastric ulcers in racing sled dogs. The initial study 
indicated that under relatively modest conditions (training runs 
up to 100 miles in a day), famotidine was effective in preventing 
gastric ulcers (7). However, a subsequent study showed that, 
under actual racing conditions, famotidine was not sufficiently 
effective in preventing severe EIGD (8). A further study was then 
conducted, which compared the efficacy high-dose famotidine 
(40  mg PO BID/~25  kg dog) with omeprazole (20  mg PO 
SID/~25 kg dog) in preventing EIGD under racing conditions. 
This study showed that, with carefully timed administration, near 
the conclusion of a long exercise bout during which minimal 
snacking has occurred, omeprazole is more effective in reducing 
the number and severity of gastric lesions in racing sled dogs than 
famotidine (8). If an additional 30 min is allowed to pass prior to 
feeding the dog, efficacy can approach 100% in preventing clini-
cally significant lesions during even the most strenuous exercise 
events.
Sucralfate, a GI protectant that binds to proteinaceous 
exudates found at ulcer sites, should be administered to dogs 
with confirmed or suspected gastric ulcers. The primary benefit 
of sucralfate is that it protects the ulcerated areas from further 
damage from gastric acid, bile, and pepsin. It has also been 
shown to have cytoprotective and antacid effects. Supportive 
care may include ensuring adequate hydration and nutrition, 
and transfusions in the case of excessive blood loss. Specific 
treatment for sequelae such as aspiration pneumonia may be 
necessary. Canine athletes, like any athlete, occasionally suffer 
from musculoskeletal injury for which NSAIDs are indicated. 
The potential contribution of NSAIDs to EIGD is unknown, but 
given the ulcerogenic potential of NSAIDs, these drugs should 
not be used before or during the types of exercise known or sus-
pected to predispose a dog to the development of EIGD. NSAIDs 
should be used judiciously in dogs who are at risk of or suspected 
to have EIGD and concurrent acid suppression therapy should 
be considered.
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